Gemzar

Cancer cells

Pharma

NuCana's twist on chemo drug Gemzar fails in phase 3 again

The failure wipes out hopes that NuCana’s attempt to improve on gemcitabine, sold by Eli Lilly as Gemzar, will improve outcomes in biliary cancer.

Nick Paul Taylor Mar 8, 2022 7:35am

singapore

ASLAN posts positive top-line varlitinib phase 2 data in breast cancer

Feb 16, 2017 10:30am